✦ LIBER ✦

Bone loss associated with the use of LHRH agonists in prostate cancer

✍ Scribed by Peters, J L; Fairney, A; Kyd, P; Patel, A; Rogers, S; Webster, J J; Vale, J A; Witherow, R O N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of LHRH agonists in prostate

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 404 KB

Usefulness of LHRH agonists in prostate

✍ McClellan, Karen 📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 163 KB

Long-term treatment with the LHRH-agonis

✍ Schröder, F.H.; Debruyne, F.J.M.; de Voogt, H.J.; Klijn, J.G.; de Jong, F.H. 📂 Article 📅 1986 🏛 Elsevier Science ⚖ 139 KB

LOSS OF LUTEINIZING HORMONE BIOACTIVITY

✍ R. ST-ARNAUD; R. LACHANCE; SUSAN J. KELLY; BELANGER. A. DUPONT; F. LABRIE 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

442 Marked loss of LH bioactivity in men

✍ R. St-Arnaud; S. Kelly; A. Dupont; A. Belanger; F. Labrie 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Tamoxifen in the rat prevents estrogen-d

✍ Goulding, A.; Gold, E.; Feng, W. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 841 KB